NRG TRANSSEPTAL NEEDLE NRG-71-C1

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2019-05-23 for NRG TRANSSEPTAL NEEDLE NRG-71-C1 manufactured by Baylis Medical Company Inc..

Event Text Entries

[145992126] Review of the device history record for the lot in question confirmed that all parts met manufacturing requirements prior to release. There is no evidence to suggest that the baylis medical device caused or contributed to the reported incident. However, as the baylis medical device was reported to be among the devices used in the procedure, baylis medical has decided to submit this report. There is no suspected device failure. The reported patient complication is an inherent risk in this type of procedure.
Patient Sequence No: 1, Text Type: N, H10


[145992127] Baylis medical was informed of a pulmonary vein isolation (pvi) procedure in which the nrg transseptal needle was used for transseptal puncture and a complication occurred. The physician performed two transseptal punctures with the nrg needle through a sl1 sheath with no issue. The physician pulled out the nrg needle to exchange for an agilis sheath. No baylis products were used again or placed inside the patient. The physician lost access with the agilis sheath but was later able to cross again through the same puncture site. The case proceeded and later, a perforation was discovered. The patient was deemed stable and did not have to leave the catheterization lab but the procedure was aborted. The nursing staff indicated that the physician felt that the baylis nrg transseptal needle nrg needle was not responsible for the perforation. The nursing staff stated that very high contact force was observed on the mapping system throughout the procedure. There is no evidence to suggest that the baylis medical device caused or contributed to the reported incident. However, as the baylis medical device was reported to be among the devices used in the procedure, baylis medical has decided to submit this report.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number9710452-2019-00016
MDR Report Key8637312
Report SourceHEALTH PROFESSIONAL
Date Received2019-05-23
Date of Report2019-05-23
Date of Event2019-04-23
Date Mfgr Received2019-04-25
Date Added to Maude2019-05-23
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactDR. MEGHAL KHAKHAR
Manufacturer Street2775 MATHESON BLVD. EAST
Manufacturer CityMISSISSAUGA, ONTARIO L4W 4P7
Manufacturer CountryCA
Manufacturer PostalL4W 4P7
Manufacturer G1BAYLIS MEDICAL COMPANY INC.
Manufacturer Street2775 MATHESON BLVD. EAST
Manufacturer CityMISSISSAUGA, ONTARIO L4W 4P7
Manufacturer CountryCA
Manufacturer Postal CodeL4W 4P7
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameNRG TRANSSEPTAL NEEDLE
Generic NameRF TRANSSEPTAL NEEDLE
Product CodeDXF
Date Received2019-05-23
Returned To Mfg2019-05-16
Model NumberNRG-71-C1
Lot NumberNGFA110918
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerBAYLIS MEDICAL COMPANY INC.
Manufacturer Address5959 TRANS-CANADA HIGHWAY MONTREAL, QUEBEC H4T 1A1 CA H4T 1A1


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-05-23

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.